Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 10OTHER 8NIH 6NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Leukemia 9Leukemia, Myeloid, Acute 7Prostatic Neoplasms 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Congenital Abnormalities 2Pain 1Ovarian Neoplasms 1Neutropenia 1Myeloproliferative Disorders 1Lymphoma 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Down Syndrome 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Carcinoma, Ovarian Epithelial 1Brenner Tumor 1Breast Neoplasms 1

Interventions

bicalutamide 23Radiotherapy 21Goserelin 21Docetaxel 19Flutamide 17Leuprolide 16Prednisone 11Radiotherapy, Conformal 10Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Triptorelin Pamoate 8Buserelin 8Estramustine 7Androgen Antagonists 7Brachytherapy 6luprolide acetate gel depot 5enzalutamide 5Paclitaxel 5nilutamide 4darolutamide 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Radiation 4Mitoxantrone 4Carboplatin 4orteronel 3apalutamide 3Selenium 3Orchiectomy 3Magnetic Resonance Spectroscopy 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Prostatic Neoplasms × Mitoxantrone × Clear all
NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Eastern Cooperative Oncology Group

Phase 2 Completed
Genitourinary

Prostatic Neoplasms

NCT00004124 2022-12-30

S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

SWOG Cancer Research Network

Phase 3 Completed
983 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT00003232 2020-04-03

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Canadian Cancer Trials Group

Phase 3 Completed
227 enrolled
Genitourinary

Pain, Prostatic Neoplasms

NCT00004001 2014-02-25

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
770 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡